Who’s running the Sandoz sale process?
Anyone know? Looks like PJT has been the go-to advisor for Novartis for their recent acquisitions/ sales
Anyone know? Looks like PJT has been the go-to advisor for Novartis for their recent acquisitions/ sales
| +297 | Predicted 1Q 2027 Story - UBS IB blames Outlook Outage for Down Quarter | 41 | 1d |
| +292 | Houston 2026 Oil & Gas Investment Banking Rankings | 82 | 52m |
| +251 | Why leave restructuring for M&A? | 33 | 4h |
| +185 | Incoming TPH Analysts Larping as PWP on LinkedIn | 27 | 1d |
| +148 | Laid off from UBS TMT - AMA! | 39 | 34m |
| +58 | Rogo Changing The Game | 22 | 4h |
| +46 | I built a game to help me practice fundamentals like DCF, merger models and LBOs. Roast it? | 8 | 18h |
| +33 | Thoughts on William Blair? | 15 | 4h |
| +26 | What’s the current state of IBD at BofA? | 35 | 1h |
| +26 | UBS FIG Deal Flows / Hours / Culture | 34 | 1h |
Career Resources
Honestly, I would not be surprised if it went to CVP.
I want some of that LSD IP. Hoffman used to go to these secret Friday night dinners that the elite of the psychedelic community put on with escorts.
Neither PJT nor CVP
GS
I would believe it. For the Medline buyout last year, GS was lead advisor to Medline while a whole conglomerate of BB's and CVP where on the PE syndicate side. Not sure how many of those BB's had an advisory role or if they were brought in purely for financing.
Believe BofA is involved
Optio odio et ut natus. Unde et maiores omnis in et vel.
Quia qui recusandae sequi necessitatibus id. Vel blanditiis iure nesciunt tenetur minus et omnis rerum. Non earum excepturi officiis.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...